Empirical modeling of T cell activation predicts interplay of host cytokines and bacterial indole
暂无分享,去创建一个
Arul Jayaraman | A. Jayaraman | R. Alaniz | D. Howsmon | Juergen Hahn | Daniel P Howsmon | Juergen Hahn | Shelby Steinmeyer | Robert C Alaniz | S. Steinmeyer | Shelby Steinmeyer
[1] S. Kang,et al. Short chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway , 2014, Mucosal Immunology.
[2] Kyongbum Lee,et al. Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities , 2014, Molecular Pharmacology.
[3] A. Liston,et al. Regulatory T Cells , 2011, Methods in Molecular Biology.
[4] D. Hafler,et al. FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.
[5] H. Vogel,et al. Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. , 2010, Journal of proteome research.
[6] Lin Bin. FOXP3~+ regulatory T cells , 2010 .
[7] D. Cua,et al. Th17 cell development: from the cradle to the grave , 2013, Immunological reviews.
[8] R. D. Hatton,et al. The Th17 family: flexibility follows function , 2013, Immunological reviews.
[9] George Cybenko,et al. Approximation by superpositions of a sigmoidal function , 1989, Math. Control. Signals Syst..
[10] M. Grisham,et al. Gut‐associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation , 2010, Annals of the New York Academy of Sciences.
[11] Lennart Ljung,et al. System Identification: Theory for the User , 1987 .
[12] F. Powrie,et al. The interleukin‐23 axis in intestinal inflammation , 2008, Immunological reviews.
[13] T. Chatila,et al. A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis1 , 2009, The Journal of Immunology.
[14] Aristides G. Eliopoulos,et al. The gut microbiota in mouse models of inflammatory bowel disease , 2014, Front. Cell. Infect. Microbiol..
[15] W. Garrett,et al. Gut microbiota, metabolites and host immunity , 2016, Nature Reviews Immunology.
[16] F. Powrie,et al. CD4+ T-cell subsets in intestinal inflammation , 2013, Immunological reviews.
[17] K. Tanaka,et al. Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells , 2008, Clinical and experimental immunology.
[18] S. Rutz,et al. IL‐22, not simply a Th17 cytokine , 2013, Immunological reviews.
[19] A. Rudensky,et al. Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.
[20] M. Tomita,et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.
[21] Wendell A. Lim,et al. Cell-Based Therapeutics: The Next Pillar of Medicine , 2013, Science Translational Medicine.
[22] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[23] B. Stockinger,et al. Differential Influences of the Aryl Hydrocarbon Receptor on Th17 Mediated Responses in vitro and in vivo , 2013, PloS one.
[24] H. Akaike. A new look at the statistical model identification , 1974 .
[25] D. Vignali,et al. How regulatory T cells work , 2008, Nature Reviews Immunology.
[26] M. Levings,et al. Regulatory T‐cell therapy for inflammatory bowel disease: more questions than answers , 2012, Immunology.
[27] A. Jayaraman,et al. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation , 2009, Proceedings of the National Academy of Sciences.
[28] M. Neurath,et al. Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis , 2005, Gut.
[29] V. Jordan. SERMs: meeting the promise of multifunctional medicines. , 2007, Journal of the National Cancer Institute.
[30] F. Powrie,et al. Dendritic cells in intestinal immune regulation , 2008, Nature Reviews Immunology.
[31] E. Zuccato,et al. Role of bile acids and metabolic activity of colonic bacteria in increased risk of colon cancer after cholecystectomy , 1993, Digestive Diseases and Sciences.
[32] F. Powrie,et al. Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.
[33] Jay K Kolls,et al. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. , 2013, Annual review of pathology.
[34] D. Artis,et al. Intestinal bacteria and the regulation of immune cell homeostasis. , 2010, Annual review of immunology.
[35] Sang-Uk Seo,et al. Role of the gut microbiota in immunity and inflammatory disease , 2013, Nature Reviews Immunology.
[36] A. Yoshimura,et al. In Vitro Th Differentiation Protocol. , 2016, Methods in molecular biology.
[37] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[38] Toshifumi Hibi,et al. Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease , 2012, PloS one.
[39] C. Baecher-Allan,et al. Human regulatory T cells and their role in autoimmune disease , 2006, Immunological reviews.
[40] Madhav V. Marathe,et al. Systems Modeling of Molecular Mechanisms Controlling Cytokine-driven CD4+ T Cell Differentiation and Phenotype Plasticity , 2013, PLoS Comput. Biol..
[41] S. Barry,et al. Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease , 2009, Journal of Clinical Immunology.
[42] J. Stroehlein,et al. Fecal skatole and indole and breath methane and hydrogen in patients with large bowel polyps or cancer , 1985, Journal of Cancer Research and Clinical Oncology.